Natco Pharma consolidated net profit declines 43.68% in the March 2021 quarter

Sales decline 27.15% to Rs 331.30 crore

Net profit of Natco Pharma declined 43.68% to Rs 53.00 crore in the quarter ended March 2021 as against Rs 94.10 crore during the previous quarter ended March 2020. Sales declined 27.15% to Rs 331.30 crore in the quarter ended March 2021 as against Rs 454.80 crore during the previous quarter ended March 2020.

For the full year,net profit declined 4.32% to Rs 440.90 crore in the year ended March 2021 as against Rs 460.80 crore during the previous year ended March 2020. Sales rose 7.16% to Rs 2052.10 crore in the year ended March 2021 as against Rs 1915.00 crore during the previous year ended March 2020.

 

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales331.30454.80 -27 2052.101915.00 7 OPM %23.0028.21 -29.5430.42 - PBDT101.10147.20 -31 696.50668.50 4 PBT70.70116.70 -39 579.60568.70 2 NP53.0094.10 -44 440.90460.80 -4

Powered by Capital Market - Live News